Low Concentration of Pingyangmycin Combined with Dexamethasone Injection in the Treatment of Superficial Lip Venous Malformations
-
- Ma Yanhong
- Department of Stomatology, XuZhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University
-
- Wu Ruihan
- Department of Stomatology, XuZhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University
-
- Zheng Hao
- Department of Stomatology, XuZhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University
-
- Meng Jian
- Department of Stomatology, XuZhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University
-
- Han Kun
- Department of Stomatology, XuZhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University
-
- Gao Xinbao
- Department of Surgery for Vascular Thyroid and Hernia, XuZhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University
-
- Wei Jingjian
- Department of Stomatology, XuZhou Central Hospital, Xuzhou Clinical School of Xuzhou Medical University
この論文をさがす
抄録
<p>To observe the clinical effect of low-concentration pingyangmycin (PYM) combined with dexamethasone (DXM) as an intralesional injection in the treatment of superficial lip venous malformations (VMs). From March 2018 to October 2021, the clinical data of 25 patients with superficial lip VMs treated by PYM combined with DXM as an injection were retrospectively analyzed. A mixture of PYM 8 mg, DXM 5 mg and 2% lidocaine at a concentration of 1 mg/l (pingyangmycin) was used for the intralesional injections. Repeated injections could be given at intervals of 2-3 weeks. The patients were followed up for 6-18 months after treatment. Of the 25 patients, PYM combined with DXM as an injection was administered once in 13 patients, twice in 7 patients and three times in 5 patients. According to the evaluation standard of curative effect, the clinical outcome was excellent in 16 patients, good in 6 patients, and fair in 3 patients. No recurrence, ulcers, fever or other serious complications were encountered. Low-concentration PYM combined with DXM as an injection is a safe, effective therapy for superficial VMs of the lips, and the cosmetic appearance and function can be maintained to the maximum extent.</p>
収録刊行物
-
- Journal of Hard Tissue Biology
-
Journal of Hard Tissue Biology 32 (2), 151-154, 2023
硬組織再生生物学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390858829326978176
-
- NII書誌ID
- AA11074332
-
- ISSN
- 1880828X
- 13417649
-
- NDL書誌ID
- 032865230
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
-
- 抄録ライセンスフラグ
- 使用不可